Literature DB >> 30853594

The Optimal Choice of Local Therapy for Stage IIIA-N2 NSCLC: Is Radiotherapy Inferior to Surgery?

Valerio Nardone1, Pierpaolo Correale2, Cesare Guida3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30853594     DOI： 10.1016/j.athoracsur.2019.01.071

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


× No keyword cloud information.
  1 in total

1.  Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial.

Authors:  S Senan; M Özgüroğlu; D Daniel; A Villegas; D Vicente; S Murakami; R Hui; C Faivre-Finn; L Paz-Ares; Y L Wu; H Mann; P A Dennis; S J Antonia
Journal:  ESMO Open       Date:  2022-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.